Close
Nordic 9Nordic 9

Agilent Technologies (investor - Corporate Investor)

United States agilent.com
See something wrong or missing? Let us know
Offices:Santa Clara

Agilent Technologies, Inc. is an American public research, development and manufacturing company established in 1999 as a spin-off from Hewlett-Packard.

Average round investment:52.38M USD
Average number per year:1.3
Distribution: 2024 (2)2021 (1)2020 (1)
Portfolio companies: United Kingdom BiofidelityUnited Kingdom TagomicsFrance DNA Script
Mostly invests in: United Kingdom United Kingdom (3) Health services (4)
See the entire list

Showing 3 of 4 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Agilent Technologies

Name Criteria
France Lauxera Capital Partners
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom, France
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States What If Ventures
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States Versant Ventures
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
United States Kairos
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.3
  • Active last 12 months: Yes
Belgium Bioqube Ventures
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United States Longitude Capital
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: France
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Arch Venture Partners
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.2
  • Active last 12 months: Yes
United States Research Corporation Technologies
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Germany PS Capital
73%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Patient Square Capital
73%
  • Range for average deal size: 50M - 100M USD
  • Similar verticals: Health services, Biotech
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
Top